From: An enhancer peptide for membrane-disrupting antimicrobial peptides
MBC (μg/mL) | ||
---|---|---|
NP4P-a | NP4P+ | |
ASABF-αb | ||
Staphylococcus aureus IFO12732 | 3 | 0.3 |
Micrococcus luteus IFO12708 | 5 | 2 |
Bacillus subtilis IFO3134 | 8 | 3 |
Escherichia coli JM109 | 3 | 0.3 |
Pseudomonas aeruginosa IFO3899 | 5 | 2 |
Salmonella typhimurium IFO13245 | 3 | 2 |
Serratia marcescens IFO3736 | 3 | 1.5 |
Polymyxin Bb | ||
Escherichia coli JM109 | 3 | 0.3 |
Pseudomonas aeruginosa IFO3899 | 5 | 2.5 |
Salmonella typhimurium IFO13245 | 5 | 2.5 |
Serratia marcescens IFO3736 | 5 | 1 |
Nisinb | ||
Staphylococcus aureus IFO12732 | 5 | 2 |
Indolicidinc | ||
Staphylococcus aureus IFO12732 | 10 | 10 |
Escherichia coli JM109 | 10 | 10 |
Ampicillinc | ||
Staphylococcus aureus IFO12732 | 250 | 250 |
Kanamycinc | ||
Staphylococcus aureus IFO12732 | 3 | 3 |
Enrofloxacinc | ||
Staphylococcus aureus IFO12732 | 0.25 | 0.25 |